CPT® Code 0443T

Add-On Code

Real-time spectral analysis of prostate tissue by fluorescence spectroscopy, including imaging guidance (List separately in addition to code for primary procedure)

The procedure described by CPT® Code 0443T involves the use of real-time spectral analysis of prostate tissue through fluorescence spectroscopy, which is a technique employed to identify malignant prostate tissue. This procedure is particularly significant when performed in conjunction with a needle or punch prostate biopsy, as it enhances the accuracy of diagnosing prostate cancer. Fluorescence spectroscopy (FS) operates by analyzing naturally fluorescing endogenous proteins and enzymes present in body tissues. When these tissues are subjected to photon-electron stimulation, they scatter signals that can be measured. The concentration of endogenous fluorophores in prostate tissue varies depending on the presence of disease, making FS a valuable tool for quantifying these variations and identifying malignant lesions. During the procedure, a custom fluorometer, which is equipped with light-emitting diodes and a spectrometer, is utilized to read the fluorescence signals. This device interfaces with specialized software designed to differentiate between benign and malignant tissues, providing a histopathological grade for suspected malignant tumors. The procedure employs an optical biopsy needle that contains a built-in light-sensitive optical probe or sensor, along with fibers that facilitate tissue excitation and the collection of spectral data. This needle is advanced into the prostate under the guidance of fluorescence spectroscopy, allowing for real-time analysis. The ability to obtain spectral data in vivo significantly enhances the diagnostic yield of the biopsy sample, as it aids in recognizing suspicious areas within the prostate gland and improves the overall accuracy of prostate cancer diagnosis.